Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALIPSO: Lisuride Infusion in Advanced Parkinson's Disease
NCT00408915Phase 3Completed
- Sponsor
- Axxonis Pharma AG
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lisuride in Parkinson's disease (PD), sponsored by Axxonis Pharma AG. Started Jul 2006; status: completed.
02
Drugs
lisuride
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00408915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408915.